We are live on
!
Find out more
Kymera Therapeutics
KYMR
KYMR
176 hedge funds and large institutions have $3.27B invested in Kymera Therapeutics in 2024 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 56 increasing their positions, 64 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
125% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 16
62% more capital invested
Capital invested by funds: $2.01B → $3.27B (+$1.26B)
12% more funds holding
Funds holding: 157 → 176 (+19)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
1.53% less ownership
Funds ownership: 109.83% → 108.3% (-1.5%)
13% less repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 64
27% less call options, than puts
Call options by funds: $2.82M | Put options by funds: $3.88M
Holders
176
Holders Change
+19
Holders Change %
+12.1%
% of All Funds
2.53%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
36
Increased
56
Reduced
64
Closed
16
Calls
$2.82M
Puts
$3.88M
Net Calls
-$1.06M
Net Calls Change
-$1.33M
Top Buyers
Top Sellers
| 1 |
AG
Artal Group
Luxembourg
|
-$89.7M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$39.7M |
| 3 |
AVLSA
Atlas Venture Life Science Advisors
Cambridge,
Massachusetts
|
-$20M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$11.4M |
| 5 |
Goldman Sachs
New York
|
-$10.5M |
